These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7000879)

  • 1. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.
    Luisi M; Franchi F
    J Endocrinol Invest; 1980; 3(3):305-8. PubMed ID: 7000879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone replacement on sexual behavior in hypogonadal men.
    Salmimies P; Kockott G; Pirke KM; Vogt HJ; Schill WB
    Arch Sex Behav; 1982 Aug; 11(4):345-53. PubMed ID: 7149969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men.
    Jockenhövel F; Bullmann C; Schubert M; Vogel E; Reinhardt W; Reinwein D; Müller-Wieland D; Krone W
    Metabolism; 1999 May; 48(5):590-6. PubMed ID: 10337859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men.
    Jockenhövel F; Minnemann T; Schubert M; Freude S; Hübler D; Schumann C; Christoph A; Ernst M
    Eur J Endocrinol; 2009 May; 160(5):815-9. PubMed ID: 19225035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
    Skakkebaek NE; Bancroft J; Davidson DW; Warner P
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):49-61. PubMed ID: 7014044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.
    O'Carroll R; Shapiro C; Bancroft J
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):527-38. PubMed ID: 3910302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various modes of androgen substitution therapy on erythropoiesis.
    Jockenhövel F; Vogel E; Reinhardt W; Reinwein D
    Eur J Med Res; 1997 Jul; 2(7):293-8. PubMed ID: 9233903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of mesterolone, a male sex hormone in depressed patients (a double blind controlled study).
    Itil TM; Michael ST; Shapiro DM; Itil KZ
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):331-7. PubMed ID: 6431212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effects of testosterone undecanoate in adult men with Klinefelter's syndrome: a controlled study.
    Wu FC; Bancroft J; Davidson DW; Nicol K
    Clin Endocrinol (Oxf); 1982 May; 16(5):489-97. PubMed ID: 7083601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral testosterone undecanoate in hypogonadal male patients.
    Franchimont P; Kicovic PM; Mattei A; Roulier R
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):313-20. PubMed ID: 102469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
    Nieschlag E; Büchter D; Von Eckardstein S; Abshagen K; Simoni M; Behre HM
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):757-63. PubMed ID: 10619981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgen on sexual behavior in hypogonadal men.
    Davidson JM; Camargo CA; Smith ER
    J Clin Endocrinol Metab; 1979 Jun; 48(6):955-8. PubMed ID: 447801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenic treatment with depot mesterolone in dyspermia.
    De Aloysio D; Nardi M; Busacchi P; Flamigni C
    Acta Eur Fertil; 1975 Jun; 6(2):125-51. PubMed ID: 242176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depot mesterolone in the management of male hypogonadism].
    Leone G; Petrosino L
    Clin Ter; 1976 Nov; 79(3):255-61. PubMed ID: 797514
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.